S100P and breast carcinoma: In further investigations, four breast cancer cell lines were screened for mRNA expression of MT1F, MT1E, SLC30A1, and S100P after treatment with BA or CAI3 and showed an upregulation of MT1F, MT1E, SLC30A1, and S100P in four breast cancer cell lines (Table 2).